CSPC INNOVATION PHARMACEUTICAL CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 33.3 CNY | +3.44% |
|
+9.87% | +9.12% |
| Apr. 22 | CSPC Innovation Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| Apr. 19 | China's drugmakers can't sell mRNA shots but haven't quit yet | RE |
| Sales 2024 * | 3.09B 427M | Sales 2025 * | 4.05B 559M | Capitalization | 46.77B 6.46B |
|---|---|---|---|---|---|
| Net income 2024 * | 806M 111M | Net income 2025 * | 1.06B 146M | EV / Sales 2024 * | 14.6 x |
| Net cash position 2024 * | 1.57B 217M | Net cash position 2025 * | 5B 691M | EV / Sales 2025 * | 10.3 x |
| P/E ratio 2024 * |
59
x | P/E ratio 2025 * |
45.2
x | Employees | 1,887 |
| Yield 2024 * |
0.75% | Yield 2025 * |
0.44% | Free-Float | 22.73% |
More Fundamentals
* Assessed data
More news
| 1 day | +3.44% | ||
| 1 week | +9.87% | ||
| Current month | +8.00% | ||
| 1 month | +4.53% | ||
| 3 months | +22.54% | ||
| 6 months | +69.68% | ||
| Current year | +9.12% |
1 week
27.52
33.93
1 month
27.5233.93
Current year
19.6935.67
1 year
9.0940.62
3 years
5.3640.62
5 years
5.3640.62
10 years
4.9840.62
| Managers | Title | Age | Since |
|---|---|---|---|
Feng Han
CEO | Chief Executive Officer | 50 | 15-12-31 |
Long Dai
DFI | Director of Finance/CFO | 32 | 23-04-06 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Wei Dong Pan
CHM | Chairman | 55 | - |
Huai Yu Wang
BRD | Director/Board Member | 61 | 15-12-31 |
Ji Yong Zhang
CHM | Chairman | - | 15-12-31 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-25 | 33.3 | +3.44% | 13,140,460 |
| 24-04-24 | 32.19 | +5.26% | 15,204,143 |
| 24-04-23 | 30.58 | +2.29% | 16,912,355 |
| 24-04-22 | 29.9 | +0.11% | 7,297,285 |
| 24-04-19 | 29.87 | -1.46% | 13,829,447 |
End-of-day quote Shenzhen S.E., April 24, 2024
More quotes
CSPC Innovation Pharmaceutical Co Ltd is a China-based company principally engaged in the research and development, production and sales of functional foods. The Company's main products include caffeine products, vitamin products and other functional foods. The Companyâs caffeine products are mainly caffeine, including a small amount of theophylline, aminophylline and theobromine. The vitamin products are mainly vitamin C tablets, including a small amount of vitamin C drinks. The Company mainly distributes its products both in the domestic market and to overseas markets.
Sector
Food Processing
Calendar
2024-05-15
- Extraordinary Shareholders Meeting
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
33.3
CNY
Average target price
40.1
CNY
Spread / Average Target
+20.41%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +9.12% | 6.24B | |
| +7.90% | 7.69B | |
| +0.34% | 7.29B | |
| -9.51% | 3.65B | |
| -12.58% | 3.43B | |
| -13.90% | 1.16B | |
| +8.48% | 961M | |
| -41.81% | 918M | |
| -19.51% | 841M | |
| -17.59% | 790M |
- Stock Market
- Equities
- 300765 Stock
